Ana Coutinho Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Coutinho Santos has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- João Abecasis
Cardiology Department, Hospital de Santa Cruz, Unidade Local de Saúde de Lisboa Ocidental , Av. Prof. Dr. Reinaldo dos Santos, Carnaxide, Lisbon 2790-134
6 shared publications - Pedro Freitas
Department of Cardiology, Hospital Santa Cruz, Unidade Local de Saúde Lisboa Ocidental, 2790-134 Carnaxide, Portugal
6 shared publications - Carla Saraiva
Hospital Santa Cruz , Lisbon , Portugal
5 shared publications Carla Saraiva
Hospital de Santa Cruz, Radiology department, Lisboa, 2790-134, Portugal
4 shared publicationsMiguel Mendes
Hospital de Santa Cruz, Cardiology department, Lisboa, 2790-134, Portugal
4 shared publications- Sara Guerreiro
Cardiology Department, Hospital de Santa Cruz, Unidade Local de Saúde de Lisboa Ocidental , Avenida Prof. Dr. Reinaldo dos Santos, 2790-134 Carnaxide, Lisbon
4 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2026 (1)
Thyroid Pneumatosis Following Fishbone Ingestion: A Rare Case Report
Background: Thyroid pneumatosis is an extremely rare condition, previously reported only once as a complication of an ultrasound‐guided thyroid fine needle aspiration (FNA). Case Report: A 70‐year‐old male sought emergency care after experiencing a foreign body sensation in his throat. He was diagnosed with a retropharyngeal abscess caused by upper digestive tract perforation from fishbone ingestion, which was surgically extracted. Postoperative day 3, a neck computed tomography (CT) revealed gas bubbles within the thyroid parenchyma, indicative of thyroid pneumatosis, likely leading to destructive thyroiditis (TSH 0.109 µUI/mL, free T4 of 27.1 pmol/L, and free T3 of 4.08 pmol/L). A multidisciplinary team opted for a conservative approach, and the patient showed a favorable recovery. Thyroid function normalized within 2 months (TSH 2.44 mUI/mL, free T4 13.6 pmol/L, and free T3 4.58 pmol/L). Conclusion: Thyroid pneumatosis should be recognized as a potential rare complication following esophageal perforation. This is the first documented case linking destructive thyroiditis to thyroid pneumatosis.
- 1 January 2026
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2026 (1)
Open AccessThyroid Pneumatosis Following Fishbone Ingestion: A Rare Case Report
Background: Thyroid pneumatosis is an extremely rare condition, previously reported only once as a complication of an ultrasound‐guided thyroid fine needle aspiration (FNA). Case Report: A 70‐year‐old male sought emergency care after experiencing a foreign body sensation in his throat. He was diagnosed with a retropharyngeal abscess caused by upper digestive tract perforation from fishbone ingestion, which was surgically extracted. Postoperative day 3, a neck computed tomography (CT) revealed gas bubbles within the thyroid parenchyma, indicative of thyroid pneumatosis, likely leading to destructive thyroiditis (TSH 0.109 µUI/mL, free T4 of 27.1 pmol/L, and free T3 of 4.08 pmol/L). A multidisciplinary team opted for a conservative approach, and the patient showed a favorable recovery. Thyroid function normalized within 2 months (TSH 2.44 mUI/mL, free T4 13.6 pmol/L, and free T3 4.58 pmol/L). Conclusion: Thyroid pneumatosis should be recognized as a potential rare complication following esophageal perforation. This is the first documented case linking destructive thyroiditis to thyroid pneumatosis.
- Open Access
- 9 November 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (Supplement)
Using the 3D architecture of scar to predict life-threatening ventricular arrhythmias, still a long way to go
Background: Late gadolinium enhancement (LGE) has been proposed as an independent predictor of ventricular arrhythmias. Purpose: The purpose of this study was to assess if myocardial scar characterization could enhance the risk stratification for life-threatening arrhythmias and sudden cardiac death (SCD). Methods: We included patients with an indication for ICD or CRT-D implantation who underwent cardiac magnetic resonance for clinical proposes since February/2018 and in whom a 3D-LGE dataset was obtained. Patients with channelopathies (n=2) or inappropriate imaging quality (imaging artifacts; n=7) were excluded. Scar characterization using ADAS software was performed in 3D-LGE datasets in all but 16 patients, where 2D datasets were used. The primary endpoint was the composite of appropriate ICD therapy (classified as ATP or shock), sustained ventricular tachycardia or SCD. Results: A total of 116 patients were analysed (mean age 66 ± 14 years; 81% male; mean LVEF 34 ± 14%; 74 patients with ischemic and 42 with non-ischemic cardiomyopathy; 40 patients received a device in the setting of secondary prevention). During a median follow-up of 2.3 years (IQR 1.3 – 3.3 years) there were 23 events (18 appropriate ICD therapies [9 shocks and 9 ATP], 3 episodes of VT under the threshold for ICD therapy and 2 SCD). No statistically significant differences were found between patients with or without events in terms of scar mass, border zone (BZ) mass, BZ channels (BZC), BZC mass, number of channels detected, and scar heterogeneity (BZ mass / scar mass ratio) - all p values > 0.2 – Figure. Restricting the analysis to only primary prevention cases yielded similar results. Overall, 26 patients did not show any channel. Four of these (all with non-ischemic LGE) experienced an arrhythmic event, yielding a negative predictive value of 83% (95% CI 64-93%) for the absence of channels. Conclusion: In this cohort with still relatively limited follow-up duration, no single parameter reflecting scar tissue characterization was able to predict appropriate device therapies or sudden cardiac death.
- 9 November 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (Supplement)
Open AccessUsing the 3D architecture of scar to predict life-threatening ventricular arrhythmias, still a long way to go
Background: Late gadolinium enhancement (LGE) has been proposed as an independent predictor of ventricular arrhythmias. Purpose: The purpose of this study was to assess if myocardial scar characterization could enhance the risk stratification for life-threatening arrhythmias and sudden cardiac death (SCD). Methods: We included patients with an indication for ICD or CRT-D implantation who underwent cardiac magnetic resonance for clinical proposes since February/2018 and in whom a 3D-LGE dataset was obtained. Patients with channelopathies (n=2) or inappropriate imaging quality (imaging artifacts; n=7) were excluded. Scar characterization using ADAS software was performed in 3D-LGE datasets in all but 16 patients, where 2D datasets were used. The primary endpoint was the composite of appropriate ICD therapy (classified as ATP or shock), sustained ventricular tachycardia or SCD. Results: A total of 116 patients were analysed (mean age 66 ± 14 years; 81% male; mean LVEF 34 ± 14%; 74 patients with ischemic and 42 with non-ischemic cardiomyopathy; 40 patients received a device in the setting of secondary prevention). During a median follow-up of 2.3 years (IQR 1.3 – 3.3 years) there were 23 events (18 appropriate ICD therapies [9 shocks and 9 ATP], 3 episodes of VT under the threshold for ICD therapy and 2 SCD). No statistically significant differences were found between patients with or without events in terms of scar mass, border zone (BZ) mass, BZ channels (BZC), BZC mass, number of channels detected, and scar heterogeneity (BZ mass / scar mass ratio) - all p values > 0.2 – Figure. Restricting the analysis to only primary prevention cases yielded similar results. Overall, 26 patients did not show any channel. Four of these (all with non-ischemic LGE) experienced an arrhythmic event, yielding a negative predictive value of 83% (95% CI 64-93%) for the absence of channels. Conclusion: In this cohort with still relatively limited follow-up duration, no single parameter reflecting scar tissue characterization was able to predict appropriate device therapies or sudden cardiac death.
- Open Access
- 30 September 2023
- Published by Taylor & Francis in Pulmonology
- Vol. 29 (5) , 435-437
Chronic thromboembolic pulmonary hypertension – the challenging approach of a young patient with distal disease
- 30 September 2023
- Published by Taylor & Francis in Pulmonology
- Vol. 29 (5) , 435-437
Open AccessChronic thromboembolic pulmonary hypertension – the challenging approach of a young patient with distal disease
- Open Access
- 29 May 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (9) , 787-793
Predictive value of a positive stress single-photon emission computed tomography or stress cardiac magnetic resonance for ruling in obstructive coronary artery disease in a real-world setting
- 29 May 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (9) , 787-793
Open AccessPredictive value of a positive stress single-photon emission computed tomography or stress cardiac magnetic resonance for ruling in obstructive coronary artery disease in a real-world setting
- Open Access
- 24 May 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (Supplement)
Using the 3D architecture of scar to predict life-threatening ventricular arrythmias - still a long way to go
Funding Acknowledgements: Type of funding sources: None. Background: Late gadolinium enhancement (LGE) has been proposed as an independent predictor of ventricular arrhythmias. Purpose: The purpose of this study was to assess if myocardial scar characterization could enhance the risk stratification for life-threatening arrhythmias and sudden cardiac death (SCD). Methods: We included patients with an indication for ICD or CRT-D implantation who underwent cardiac magnetic resonance for clinical proposes since February/2018 and in whom a 3D-LGE dataset was obtained. Patients with channelopathies (n=2) or inappropriate imaging quality (imaging artifacts; n=7) were excluded. Scar characterization using ADAS software was performed in 3D-LGE datasets in all but 5 patients, where 2D datasets were used. The primary endpoint was the composite of appropriate ICD therapy (classified as ATP or shock) or SCD. Results: A total of 75 patients were analysed (mean age 63 ± 13 years; 83% male; mean LVEF 31 ± 13%; 50 patients with ischemic and 25 with non-ischemic cardiomyopathy; 14 patients received a device in the setting of secondary prevention). During a median follow-up of 1.4 years (IQR 0.7 – 2.4 years) there were 15 events (12 appropriate ICD therapies [8 shocks and 4 ATP] and 3 SCD). No statistically significant differences were found between patients with or without events in terms of scar mass, border zone (BZ) mass, BZ channels (BZC), BZC mass, number of channels detected, and scar heterogeneity (BZ mass / scar mass ratio) - all p values > 0.2 – Figure. Restricting the analysis to only primary prevention cases yielded similar results. Overall, 11 patients did not show any channel. Two of these experienced an arrhythmic event, yielding a negative predictive value of 80% (95% CI 75-83%) for the absence of channels. Conclusion: In this cohort with still relatively limited follow-up duration, no single parameter reflecting scar tissue characterization was able to predict appropriate device therapies or sudden cardiac death.
- 24 May 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (Supplement)
Open AccessUsing the 3D architecture of scar to predict life-threatening ventricular arrythmias - still a long way to go
Funding Acknowledgements: Type of funding sources: None. Background: Late gadolinium enhancement (LGE) has been proposed as an independent predictor of ventricular arrhythmias. Purpose: The purpose of this study was to assess if myocardial scar characterization could enhance the risk stratification for life-threatening arrhythmias and sudden cardiac death (SCD). Methods: We included patients with an indication for ICD or CRT-D implantation who underwent cardiac magnetic resonance for clinical proposes since February/2018 and in whom a 3D-LGE dataset was obtained. Patients with channelopathies (n=2) or inappropriate imaging quality (imaging artifacts; n=7) were excluded. Scar characterization using ADAS software was performed in 3D-LGE datasets in all but 5 patients, where 2D datasets were used. The primary endpoint was the composite of appropriate ICD therapy (classified as ATP or shock) or SCD. Results: A total of 75 patients were analysed (mean age 63 ± 13 years; 83% male; mean LVEF 31 ± 13%; 50 patients with ischemic and 25 with non-ischemic cardiomyopathy; 14 patients received a device in the setting of secondary prevention). During a median follow-up of 1.4 years (IQR 0.7 – 2.4 years) there were 15 events (12 appropriate ICD therapies [8 shocks and 4 ATP] and 3 SCD). No statistically significant differences were found between patients with or without events in terms of scar mass, border zone (BZ) mass, BZ channels (BZC), BZC mass, number of channels detected, and scar heterogeneity (BZ mass / scar mass ratio) - all p values > 0.2 – Figure. Restricting the analysis to only primary prevention cases yielded similar results. Overall, 11 patients did not show any channel. Two of these experienced an arrhythmic event, yielding a negative predictive value of 80% (95% CI 75-83%) for the absence of channels. Conclusion: In this cohort with still relatively limited follow-up duration, no single parameter reflecting scar tissue characterization was able to predict appropriate device therapies or sudden cardiac death.
- Open Access
- 27 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
The use of essential oils in birth care
Background and Objective: The World Health Organization (WHO) has a set of diverse practices, approaches, knowledge and beliefs in health, where plant, animal or mineral-based medicines are used, spiritual therapies, manual techniques that can be applied, separately or in combination, with the...
- 27 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessThe use of essential oils in birth care
Background and Objective: The World Health Organization (WHO) has a set of diverse practices, approaches, knowledge and beliefs in health, where plant, animal or mineral-based medicines are used, spiritual therapies, manual techniques that can be applied, separately or in combination, with the...
- Open Access
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Influence of age on the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients
Background: The 2021 Guideline for the Evaluation of Chest Pain supports the use of coronary artery calcium (CAC) score as a reasonable first-line test to identify patients with a low likelihood of obstructive coronary artery disease (CAD) who may not require additional testing (class IIa, LOE B). However, a recent study from a large cohort of Northern European patients raised concerns about the added diagnostic value of CAC=0 in younger patients. The aim of this study was to assess the influence of age on the value of CAC=0 in symptomatic patients undergoing coronary computed tomography angiography (CCTA). Methods: We conducted a two-center cross-sectional study assessing symptomatic patients with suspected CAD who underwent CAC score and CCTA. Key exclusion criteria were age <30 years, known CAD, suspected acute coronary syndrome, or symptoms other than chest pain or dyspnea. Pretest probability of obstructive CAD was calculated based on age, sex and symptom typicality, according to the guideline-recommended method. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA. The diagnostic likelihood ratios and negative predictive values (NPV) were used to assess the diagnostic value of a CAC score of 0 to rule out obstructive CAD. Results: A total of 2043 patients (mean age 60±11 years, 60% women) of whom 990 (48.5%) had a CAC score of 0 were included in the analysis. Symptom characteristics were: 38% non-anginal chest pain, 30% atypical angina, 19% dyspnea, and 13% typical chest pain. Overall, the prevalence of obstructive CAD was 12.8% (n=262). Pretest probability of obstructive CAD increased progressively with age, from 6.0% in patients young than 50 years to 20.7% in those 70 years or older. Contrariwise, the prevalence of patients with a CAC score = 0 decreased from 77% in patients younger than 50 years, to 26% in those who where 70 years or older. The added diagnostic value of a CAC score = 0 was lower in younger patients, with negative likelihood ratios ranging from 0.36 (64% decrease in the likelihood of CAD) in patients younger than 50 years, to 0.09 and 0.10 (∼90% decrease in the likelihood of CAD) in those aged 60–69 years and 70 years or older, respectively – Figure 1. Despite this, the prevalence of obstructive CAD among patients with a CAC score = 0 was low across all age groups: 2.4% (i.e., NPV = 97.6%) in those younger than 50 years, 3.0% (NPV = 97.0%) among those aged 50–59 years, 1.5% (NPV = 98.5%) in patients between 60 and 69 years, and 2.0% (NPV = 98.0%) among those 70 years or older. Conclusions: In a cohort of symptomatic patients undergoing CCTA for suspected CAD, the added diagnostic value of a CAC score of zero decreases significantly at younger ages. However, this “diminishing return” of CAC in younger patients if offset by their lower pretest probabilities, yielding high negative predictive values independently of age. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Open AccessInfluence of age on the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients
Background: The 2021 Guideline for the Evaluation of Chest Pain supports the use of coronary artery calcium (CAC) score as a reasonable first-line test to identify patients with a low likelihood of obstructive coronary artery disease (CAD) who may not require additional testing (class IIa, LOE B). However, a recent study from a large cohort of Northern European patients raised concerns about the added diagnostic value of CAC=0 in younger patients. The aim of this study was to assess the influence of age on the value of CAC=0 in symptomatic patients undergoing coronary computed tomography angiography (CCTA). Methods: We conducted a two-center cross-sectional study assessing symptomatic patients with suspected CAD who underwent CAC score and CCTA. Key exclusion criteria were age <30 years, known CAD, suspected acute coronary syndrome, or symptoms other than chest pain or dyspnea. Pretest probability of obstructive CAD was calculated based on age, sex and symptom typicality, according to the guideline-recommended method. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA. The diagnostic likelihood ratios and negative predictive values (NPV) were used to assess the diagnostic value of a CAC score of 0 to rule out obstructive CAD. Results: A total of 2043 patients (mean age 60±11 years, 60% women) of whom 990 (48.5%) had a CAC score of 0 were included in the analysis. Symptom characteristics were: 38% non-anginal chest pain, 30% atypical angina, 19% dyspnea, and 13% typical chest pain. Overall, the prevalence of obstructive CAD was 12.8% (n=262). Pretest probability of obstructive CAD increased progressively with age, from 6.0% in patients young than 50 years to 20.7% in those 70 years or older. Contrariwise, the prevalence of patients with a CAC score = 0 decreased from 77% in patients younger than 50 years, to 26% in those who where 70 years or older. The added diagnostic value of a CAC score = 0 was lower in younger patients, with negative likelihood ratios ranging from 0.36 (64% decrease in the likelihood of CAD) in patients younger than 50 years, to 0.09 and 0.10 (∼90% decrease in the likelihood of CAD) in those aged 60–69 years and 70 years or older, respectively – Figure 1. Despite this, the prevalence of obstructive CAD among patients with a CAC score = 0 was low across all age groups: 2.4% (i.e., NPV = 97.6%) in those younger than 50 years, 3.0% (NPV = 97.0%) among those aged 50–59 years, 1.5% (NPV = 98.5%) in patients between 60 and 69 years, and 2.0% (NPV = 98.0%) among those 70 years or older. Conclusions: In a cohort of symptomatic patients undergoing CCTA for suspected CAD, the added diagnostic value of a CAC score of zero decreases significantly at younger ages. However, this “diminishing return” of CAC in younger patients if offset by their lower pretest probabilities, yielding high negative predictive values independently of age. Funding Acknowledgement: Type of funding sources: None.
- 16 December 2021
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 32 (1) , 113-115
Double aortic arch: an elusive diagnosis in a child with CHD
An 18-month-old male with pulmonary atresia and ventricular septal defect presented with stridor after neonatal systemic-to-pulmonary artery shunt surgery, that persisted on follow-up. CT angiography revealed a vascular ring with balanced double aortic arch.
- 16 December 2021
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 32 (1) , 113-115
Double aortic arch: an elusive diagnosis in a child with CHD
An 18-month-old male with pulmonary atresia and ventricular septal defect presented with stridor after neonatal systemic-to-pulmonary artery shunt surgery, that persisted on follow-up. CT angiography revealed a vascular ring with balanced double aortic arch.
- 2 March 2021
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 31 (4) , 639-640
Congenital right coronary fistula to right ventricle
- 2 March 2021
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 31 (4) , 639-640
Congenital right coronary fistula to right ventricle
- 1 February 2020
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 13 (2) , 410-421
CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography
- 1 February 2020
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 13 (2) , 410-421
CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography